Diethylcarbamazine
Revision as of 12:44, 3 April 2022 by Ostermayer (talk | contribs)
Overview
Diethylcarbamazine (DEC) used globally its anti-filaricidal activity[1]
Administration
- Mechanism of Action: interferes with cyclooxygenase and lipoxygenase pathways, reducing the production of thromboxane, prostacyclin, prostaglandin and leukotrienes
- Dosage Forms:
- Routes of Administration:
- Common Trade Names:
Adult Dosing
Pediatric Dosing
Special Populations
Pregnancy Rating
Lactation risk
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
Mechanism of Action
Comments
See Also
References
- ↑ Peixoto CA et al. Anti-inflammatory effects of diethylcarbamazine: A review. European Journal of Pharmacology 734 (2014) 35–41